The Christie charity
This event is aimed at multidisciplinary healthcare professionals, who care, and/or refer cutaneous T-cell lymphoma (CTCL) patients to The Christie within the North West region, including dermatologists, clinical oncologists, haematologists, histopathologists, clinical trainees, radiotherapy staff and nurses.
- The Christie Supranetwork MDT: general updates on CTCL, current thinking , trends and clinical trials
- MDT best practice
- Interactive case presentations
- Panel discussion
MDT Approach to diagnostic challenges and subsequent management of Cutaneous T Cell Lymphoma – Wednesday 29 June 2022
|
Time |
Session |
|---|---|
|
4.00pm |
Welcome |
|
4.05pm |
An introduction to the MDT members and their roles. An explanation of how the MDT is run at The Christie, illustrating the patient pathway through diagnosis and into management |
|
4.35pm |
Newly approved therapies in CTCL |
|
4.50pm |
Clinical trials available for patients at The Christie |
|
5.00pm |
Comfort Break |
|
5.10pm |
Case Presentations highlighting diagnostic challenges and management decisions |
|
5.50pm |
Questions for the panel |
|
6.00pm |
Close of meeting |
Speakers to include:
- Prof Richard Cowan: Consultant in clinical oncology and lead of the Manchester Supra regional Cutaneous Lymphoma Service
- Dr Christina Hague: Consultant in clinical oncology
- Dr Nina Farquharson: Consultant in dermatology
- Simeon Mitton: Lymphoma clinical nurse specialist
This educational meeting is organised by The Christie School of Oncology and funded by Kyowa Kirin Ltd.
Sign up to our education events mailing list to be kept up to date with this and future events